SG Americas Securities LLC acquired a new stake in Irhythm Technologies Inc (NASDAQ:IRTC) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 32,897 shares of the company’s stock, valued at approximately $2,286,000. SG Americas Securities LLC owned 0.14% of Irhythm Technologies at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Quantamental Technologies LLC bought a new stake in Irhythm Technologies during the fourth quarter valued at approximately $55,000. Bank of Montreal Can lifted its position in Irhythm Technologies by 574.7% during the fourth quarter. Bank of Montreal Can now owns 1,120 shares of the company’s stock valued at $78,000 after purchasing an additional 954 shares during the last quarter. Rehmann Capital Advisory Group bought a new stake in Irhythm Technologies during the third quarter valued at approximately $160,000. Prudential Financial Inc. bought a new stake in shares of Irhythm Technologies in the 3rd quarter worth approximately $226,000. Finally, Janus Henderson Group PLC bought a new stake in shares of Irhythm Technologies in the 3rd quarter worth approximately $267,000. Institutional investors and hedge funds own 99.80% of the company’s stock.
Shares of NASDAQ IRTC opened at $83.19 on Tuesday. The company has a current ratio of 4.79, a quick ratio of 4.69 and a debt-to-equity ratio of 0.51. Irhythm Technologies Inc has a 52 week low of $55.18 and a 52 week high of $98.37. The firm has a market capitalization of $2.01 billion, a P/E ratio of -63.99 and a beta of 1.77.
IRTC has been the subject of a number of recent research reports. Zacks Investment Research lowered shares of Irhythm Technologies from a “buy” rating to a “hold” rating in a report on Saturday, November 3rd. Canaccord Genuity boosted their price objective on shares of Irhythm Technologies from $84.00 to $90.00 and gave the stock a “buy” rating in a report on Friday, January 11th. Finally, BidaskClub lowered shares of Irhythm Technologies from a “buy” rating to a “hold” rating in a report on Friday, October 19th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $90.88.
WARNING: This story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/4146181/sg-americas-securities-llc-acquires-shares-of-32897-irhythm-technologies-inc-irtc.html.
Irhythm Technologies Company Profile
iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.
Featured Article: Asset Allocation and Your Retirement
Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.